HCA Healthcare, Inc. vs DaVita Inc.
A head-to-head of HCA Healthcare, Inc. (HCA) and DaVita Inc. (DVA) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | HCA | DVA |
|---|---|---|
| Market Cap | $82.34B | $15.21B |
| P/E (TTM) | 12.76 | 21.98 |
| Forward P/E | 13.11 | 11.63 |
| P/S | 1.26 | 0.91 |
| P/B | -16.19 | 15.64 |
| EV/EBITDA | 9.68 | 8.90 |
| Dividend Yield | 0.83% | — |
| Profit Margin | 8.89% | 5.65% |
| Gross Margin | 41.50% | 32.25% |
| Operating Margin | 15.83% | 14.74% |
| Revenue Growth (YoY) | +4.30% | +5.96% |
| FCF Yield | 8.22% | 12.00% |
| Debt / Equity | — | 1013.79 |
| Current Ratio | 0.83 | 1.42 |
Which is better: HCA Healthcare, Inc. or DaVita Inc.?
- ✓Larger by market cap: HCA Healthcare, Inc.
- ✓Cheaper valuation (lower P/E): HCA Healthcare, Inc.
- ✓More profitable (net margin): HCA Healthcare, Inc.
- ✓Faster revenue growth: DaVita Inc.
- ✓Higher free-cash-flow yield: DaVita Inc.
Across 10 available metrics, DaVita Inc. leads 6–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.